Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Healthy Extracts (HYEX) Convertible Debt (2017 - 2025)

Healthy Extracts filings provide 9 years of Convertible Debt readings, the most recent being $247423.0 for Q2 2025.

  • On a quarterly basis, Convertible Debt changed N/A to $247423.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $247423.0, a N/A change, with the full-year FY2023 number at $530860.0, down 10.88% from a year prior.
  • Convertible Debt hit $247423.0 in Q2 2025 for Healthy Extracts, down from $566712.0 in the prior quarter.
  • In the past five years, Convertible Debt ranged from a high of $864750.0 in Q3 2021 to a low of $6750.0 in Q1 2022.
  • Median Convertible Debt over the past 5 years was $519098.5 (2022), compared with a mean of $454518.7.
  • Biggest five-year swings in Convertible Debt: skyrocketed 12711.11% in 2021 and later plummeted 98.05% in 2022.
  • Healthy Extracts' Convertible Debt stood at $171750.0 in 2021, then surged by 246.81% to $595638.0 in 2022, then decreased by 10.88% to $530860.0 in 2023, then increased by 6.75% to $566712.0 in 2024, then crashed by 56.34% to $247423.0 in 2025.
  • The last three reported values for Convertible Debt were $247423.0 (Q2 2025), $566712.0 (Q3 2024), and $530860.0 (Q4 2023) per Business Quant data.